SKI Market

Indian Indices

Sensex

78,918.90 -1,097.00
( -1.37%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

55,600.46 322.40
(0.58%)

Nikkei 225

10,286.75 -127.19
(-1.22%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532649

INE023H01027

36.7483544

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NECLIFE

229.23

EPS(TTM)

Face Value()

Div & Yield %

Back

Omkar Overseas reports standalone net loss of Rs 0.03 crore in the December 2025 quarter

Feb 07,2026

Net Loss of Omkar Overseas reported to Rs 0.03 crore in the quarter ended December 2025 as against net loss of Rs 0.03 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.

78,918.90 -1,097.00 ( -1.37%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

55,600.46 322.40 (0.58%)

10,286.75 -127.19 (-1.22%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)